-
New drugs for insomnia! The eludant of ego receptor seroinion, Dayvigo (lemborexant), is on the market in Hong Kong, China!
Time of Update: 2020-07-14
, July 09, 2020 / bio-valley smh.com.au/Eisai has announced that a new drug application for its insomnia drug Dayvigo (lemborexant) has been accepted by the Hong Kong Special Administrative Region
-
Speech is not clear, limb shake 1 year, what is your diagnosis?
Time of Update: 2020-07-14
Parkinson's disease (PD) and multi-system atrophy (multiple system atrophy, MSA) are often difficult to identify in the early stages of the disease, and some MSA patients have brain bridge "cross" o
-
Clinica Chimica Acta: What is the diagnostic value of the free-frisk light chain?
Time of Update: 2020-07-14
The detection of the oligoclonal band (OCB) in cerebrospinal fluid (CSF) is the gold standard for diagnosis of inflammation in the However, the significance of an isolated strip in The CSF is unce
-
Lancet: Study on Alzheimer's biomarker characteristics in patients with Down syndrome
Time of Update: 2020-07-14
Alzheimer's disease and its complications are the leading cause of death in adults with Down syndrome, and researchers recently examined how Alzheimer's biomarkers change in adult populations with D
-
Science: The Mac experiment reveals human evolution! Human-specific genes can cause neocortex expansion
Time of Update: 2020-07-14
Introduction: Perhaps a coincidence of 6 million years ago, a human-specific gene separated people from chimpanzees, opening up the most magical evolutionary process in natural history: the evolutio
-
Genetically modified natural killer (NK) cells to treat glioblastoma
Time of Update: 2020-07-14
Glioblastoma is the most common malignant brain tumor in adults, and current treatment options are extremely limited and often ineffective, leading to the death of most patients within 12-18 months
-
Aging: Mitochondrial peptide humanin regulates life and health
Time of Update: 2020-07-14
Humanin is a member of a new family of peptides encoded within the mitochondrial genome by a short open reading box It is conservative in animals and has neuroprotective and cellular protection re
-
Nat Med: Does Tau's molecular diversity make Alzheimer's clinicalhesis?
Time of Update: 2020-07-14
Alzheimer's disease (AD) can lead to sexual cognitive impairment, but its process estoctic, cognitive decline rates range wide existing studies have shown that the spread of tau aggregates (neural
-
After falling asleep at night, do your legs feel like worm-crawling ants? Beware of a heart attack!
Time of Update: 2020-07-14
There is such a group of people around us, he (she) quiet and sedentary will be legs deep pain, sleep at night feel like a worm crawlant, sour burning pain makes him (her) repeatedly awakened .. t
-
Stroke: Urban-rural differences in acute stroke treatment and hospitalization mortality
Time of Update: 2020-07-14
The gap in life expectancy between urban and rural residents is widening, but the underlying causes are not entirely clear Previous studies have shown that individual stroke treatment in rural are
-
The treatment of angelic syndrome ushers in a new breakthrough! FDA Grants OV101 Orphan Drug Title
Time of Update: 2020-07-14
Angel icing syndrome is a disease caused by a genetic defect Children with the disease often have a smile on their face, lack of language skills, hyperactivity, and low intelligence About 80% of pat
-
Latest Phase III Study Data for Insomnia New Drug Daridorexant
Time of Update: 2020-07-14
Insomnia is a symptom that does not go to sleep naturally It may be difficult to fall asleep (difficult to fall asleep) or it may be difficult to maintain a long period of deep sleep (difficult to m
-
A case of sand-grain meningioma
Time of Update: 2020-07-14
Meningioma was the first tumor to be discovered and described by German pathologist Virchow Meningioma is a more common intracranial tumor, the incidence rate of about 15% to 24% of intracranial tum
-
J. Neurosur Ps: Long-term stroke risk for brain haemorrhage survivors
Time of Update: 2020-07-14
A recent study in the journal Of Of, the journal Of, published a study to assess the effects of brain haemorrhage (ICH) position on the prognosis of stroke researchers included patients diagnose
-
CELL: Small glial cells reshape extracellular matrix and promote synaptic plasticity
Time of Update: 2020-07-14
Synaptic remodeling is essential for coding learning memories into neural loops Recently, researchers discovered a molecular interaction between neurons and small glial cells that drives empirically
-
Neurology: Correlation between pre-stroke metformin use, stroke severity and thrombolytic outcome
Time of Update: 2020-07-14
Recently, a study published in the journal Neurology, the study aims to assess whether the pretreatment of metformin (MET) is related to lower stroke severity and better venous thrombolysis (IVT
-
NEJM: Acute aortic aortic blocking, bridge or not bridge?
Time of Update: 2020-07-14
When blood vessel thrombosis excision is feasible and timely, or there is a mismatch between local cerebral perfusion and infarction, it has become a pre-circulatory large vascular aocstatosis a
-
Neuty: Intravenous thrombolytic therapy for patients with chronic kidney disease
Time of Update: 2020-07-14
Recently, a study published in the authoritative journal Neurology, the study aims to clarify the relationship between chronic kidney disease (CKD) and the safety and effectiveness of venous thromb
-
Alzheimer's (AD) big news! YanJian/Aishiau beta amyloid antibody aducanumab in the United States to complete the listing application submission!
Time of Update: 2020-07-14
Biogen and partner Eisai have jointly announced that they have completed a Bioproduct License Application (BLA) with the U.S Food and Drug Administration (FDA) to seek approval for the drug aducanum
-
JAMA Neurol: The "cause" of Alzheimer's disease, a gene that drives the brain's amyloid plaques for the first time
Time of Update: 2020-07-14
Alzheimer's disease (AD) is a degenerative disease In the early stages, AD is characterized by the accumulation and memory loss of amyloid beta and tau proteins in the brain Toxic beta-amyloid molec